IN2012DN01449A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01449A
IN2012DN01449A IN1449DEN2012A IN2012DN01449A IN 2012DN01449 A IN2012DN01449 A IN 2012DN01449A IN 1449DEN2012 A IN1449DEN2012 A IN 1449DEN2012A IN 2012DN01449 A IN2012DN01449 A IN 2012DN01449A
Authority
IN
India
Prior art keywords
diagnostic
blood vessels
conditions associated
pathological conditions
cancerous tissue
Prior art date
Application number
Other languages
English (en)
Inventor
Luisa Petersen Anncatrine
Hedengran Rasmussen Palle
Rosager Henriksen Jonas
Kjær Andreas
Lars Andresen Thomas
Original Assignee
Univ Denmark Tech Dtu
Rigshospitalet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Denmark Tech Dtu, Rigshospitalet filed Critical Univ Denmark Tech Dtu
Publication of IN2012DN01449A publication Critical patent/IN2012DN01449A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1449DEN2012 2009-07-17 2010-07-16 IN2012DN01449A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200900879 2009-07-17
US30078210P 2010-02-02 2010-02-02
EP10152394 2010-02-02
PCT/DK2010/050192 WO2011006510A1 (en) 2009-07-17 2010-07-16 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines

Publications (1)

Publication Number Publication Date
IN2012DN01449A true IN2012DN01449A (ko) 2015-06-05

Family

ID=43448962

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1449DEN2012 IN2012DN01449A (ko) 2009-07-17 2010-07-16

Country Status (7)

Country Link
US (2) US8920775B2 (ko)
EP (1) EP2453927B1 (ko)
JP (1) JP5872466B2 (ko)
AU (1) AU2010272957B2 (ko)
CA (1) CA2768444A1 (ko)
IN (1) IN2012DN01449A (ko)
WO (1) WO2011006510A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5947807B2 (ja) 2010-12-14 2016-07-06 テクニカル ユニバーシティ オブ デンマークＴｅｃｈｎｉｃａｌ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｄｅｎｍａｒｋ ナノ粒子組成物への放射性核種の封入
AU2013249307B2 (en) 2012-04-17 2017-11-09 Merrimack Pharmaceuticals, Inc. Compositions and methods for non-invasive imaging
US9480759B2 (en) * 2012-11-21 2016-11-01 Serene, Llc Tin-117m somatostatin receptor binding compounds and methods
US20160022842A1 (en) * 2013-03-11 2016-01-28 Wayne State University Formation and uses of europium
US10781178B2 (en) 2015-08-12 2020-09-22 The General Hospital Corporation 8-hydroxyquinoline derivatives as diagnostic and therapeutic agents
US11633502B2 (en) 2016-03-07 2023-04-25 Memorial Sloan Kettering Cancer Center Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use
US20220023450A1 (en) * 2018-09-11 2022-01-27 Memorial Sloan Kettering Cancer Center Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use
US11478493B2 (en) * 2019-03-08 2022-10-25 University Of South Carolina Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers
WO2023240135A2 (en) 2022-06-07 2023-12-14 Actinium Pharmaceuticals, Inc. Bifunctional chelators and conjugates

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386146B1 (en) 1987-11-04 1993-04-28 Vestar, Inc. Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy
US5688488A (en) 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5525232A (en) * 1990-03-02 1996-06-11 The Liposome Company, Inc. Method for entrapment of cationic species in lemellar vesicles
JPH075561B2 (ja) 1991-12-17 1995-01-25 工業技術院長 α−アミノ酸のジアミド誘導体
US5837282A (en) * 1996-10-30 1998-11-17 University Of British Columbia Ionophore-mediated liposome loading
US6306393B1 (en) * 1997-03-24 2001-10-23 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
US5945502A (en) 1997-11-13 1999-08-31 Xerox Corporation Electroluminescent polymer compositions and processes thereof
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
DE10012782A1 (de) * 2000-03-16 2001-09-20 Boellhoff Gmbh Verbindungsanordnung zum Anbringen eines Befestigungselementes an einem Bauteil
EP1616182A4 (en) * 2003-03-18 2008-04-16 Ethicon Inc REPLACEMENT ENZYMOTHERAPY WITH 17-BETA-HYDROXYSTEROID DESHYDROGENASE TYPE 2
WO2004082626A2 (en) 2003-03-18 2004-09-30 Ethicon, Inc. Aromatase inhibitor diagnosis and therapy
WO2006021008A2 (en) 2004-08-20 2006-02-23 Lind Stuart E Ionophores as cancer chemotherapeutic agents
EP1796729A4 (en) * 2004-10-06 2010-12-08 Bc Cancer Agency LIPOSOME WITH IMPROVED ARZNE RETENTION FOR THE TREATMENT OF CANCER
GB0423565D0 (en) * 2004-10-22 2004-11-24 Algeta As Formulation
ITMI20050328A1 (it) 2005-03-03 2006-09-04 Univ Degli Studi Milano Composti peptidomimetrici e preparazione di derivati biologicamente attivi
CA2648099C (en) * 2006-03-31 2012-05-29 The Brigham And Women's Hospital, Inc System for targeted delivery of therapeutic agents
TW200922630A (en) 2007-09-26 2009-06-01 Nat Health Research Institutes Liposome compositions useful for tumor imaging and treatment
WO2009140215A2 (en) 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
BR112014010291A2 (pt) * 2011-10-31 2017-04-18 Mallinckrodt Llc composições de lipossoma combinacionais para terapia de câncer

Also Published As

Publication number Publication date
JP5872466B2 (ja) 2016-03-01
JP2012533523A (ja) 2012-12-27
US20120213698A1 (en) 2012-08-23
WO2011006510A1 (en) 2011-01-20
US8920775B2 (en) 2014-12-30
EP2453927B1 (en) 2019-05-15
EP2453927A1 (en) 2012-05-23
US20150202336A1 (en) 2015-07-23
CA2768444A1 (en) 2011-01-20
AU2010272957B2 (en) 2016-03-03
EP2453927A4 (en) 2013-01-23
AU2010272957A1 (en) 2012-03-08

Similar Documents

Publication Publication Date Title
IN2012DN01449A (ko)
Caudell et al. The future of personalised radiotherapy for head and neck cancer
You et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma–A case-matched comparison
Castaldi et al. Can “early” and “late” 18F-FDG PET–CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
WO2008008483A3 (en) Dendrimer based compositions and methods of using the same
NZ605674A (en) X-ray imaging at low contrast agent concentrations and/or low dose radiation
WO2013089882A3 (en) Recurrent gene fusions in breast cancer
WO2014205555A8 (en) Methods and uses for diagnosis and treatment of prostate cancer
EP3208615A3 (en) Uses of labeled hsp90 inhibitors
WO2012012750A8 (en) Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
MX2015001716A (es) Niclosamida para el tratamiento de tumores solidos.
NZ710436A (en) Biospecific agents for bone
Li et al. Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients
CO6382138A2 (es) N-cadherina: blanco para diagnosis y terapia de cáncer
GB201121914D0 (en) Method for patient selection
Demirci et al. The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer
De Waele et al. Response assessment of hormonal therapy in prostate cancer by [11C] choline PET/CT
MX340487B (es) Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.
MX2008016493A (es) Metodo para la deteccion de diagnostico de cancer que implica cebadores y sondas para la deteccion especifica del marcador mage-3.
WO2007136856A3 (en) Heyl as a therapeutic target and a diagnostic marker for neoplasia and uses therefor
UA56157U (ru) Способ предоставления помощи больным с пост-травматической отоликвореей в остром периоде черепно-мозговой травмы при переломах височной кости
UA60606U (ru) Способ стереотаксической биопсии очаговых образований головного мозга глубинной локализации
MX336321B (es) 99mtc-tat-bombesina como un nuevo radiofarmaco para la deteccion temprana de cancer de mama.
Emmett et al. Imaging for melanoma and non-melanoma skin cancers
Jung et al. False-positive F-18 FDG PET/CT from foreign body reaction on anterior chest wall after endoscopic total thyroidectomy via axillo-breast approach for thyroid cancer: two case reports